María Ángeles López‐García

Author

Also Known As

Maria A Lopez-Garcia, Maria A Lopez‐Garcia, Maria A. Lopez-Garcia, Maria A. Lopez-García, Maria A. Lopez‐Garcia, Maria Angeles Lopez-Garcia, Maria Angeles Lopez-García, Maria Angeles López-García, María A. López-García, María Lopez-García

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Virgen del Rocío Breast Cancer Now Institute of Cancer Research Instituto de Biomedicina de Sevilla Universidad de Sevilla

MÁ

About

María Ángeles López‐García is an author at Hospital Universitario Virgen del Rocío specializing in medicine, tumor biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1.5K
2	Cell Biology	9	9	1.3K
3	Health Sciences	2	2	100
4	Biostatistics	1	1	44
5	Immunology	1	1	15

María Ángeles López‐García

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer Nicholas C. Turner, Alex Pearson, Rachel Sharpe, Cancer Research Endocrine OncologyBreast OncologyEndocrine-related CancerMedicineCancer Cell Biology	2010	712
The molecular underpinning of lobular histological growth pattern: a genome‐wide transcriptomic analysis of invasive lobular carcinomas and grade‐ and molecular subtype‐matched invasive ductal carcinomas of no special type Britta Weigelt, Felipe C. Geyer, Rachael Natrajan, The Journal of Pathology	2009	234
Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma María Ángeles Castilla, Gema Moreno‐Bueno, Laura Romero‐Pérez, The Journal of Pathology	2010	226
Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer Konstantin J. Dedes, Rachael Natrajan, Maryou Lambros, European Journal of Cancer Specific SubgroupsSystems BiologyBreast OncologyBreast CancerMicrorna Detection	2010	149
MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes María Ángeles Castilla, Juan Díaz‐Martín, David Sarrió, PLoS ONE Breast OncologySpontaneous EmtPathologyCancer BiologyTumor Biology	2012	100
Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer Juan Díaz‐Martín, María Ángeles López‐García, Laura Romero‐Pérez, Endocrine Related Cancer	2015	87
PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study Maryou B. Lambros, Rachael Natrajan, Felipe C. Geyer, Modern Pathology Tumor BiologyRadiation OncologyBreast OncologyMedicineCancer Genomics	2010	72
Pathogenetic Pathways in Ovarian Endometrioid Adenocarcinoma Julia T. Geyer, María Ángeles López‐García, Carolina Sánchez‐Estévez, The American Journal of Surgical Pathology Dualistic PathwayTumoral PathologyEndocrine-related CancerMedicineKras Mutation	2009	72
The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers Tarek M. Abdel-Fatah, Desmond G. Powe, Johnson Agboola, The Journal of Pathology Radiation OncologyBreast OncologyOncologyMedicinePathology	2009	64
VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer María Ángeles Castilla, María Ángeles López‐García, M. Atienza, Endocrine Related Cancer	2014	62

Page 1